GlassScriptPhysician profile
T Franklin King
NPI 1336148600
$1,428.91
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $105 · 2021: $355 · 2022: $442 · 2023: $250 · 2024: $14.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $264.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $417.27 | 2019-2023 | |
| Astellas Pharma US INC | $169.66 | 2019-2023 | Veozah, Cresemba |
| Exeltis, USA INC. | $102.88 | 2019-2024 | Slynd |
| Mayne Pharma Commercial LLC | $86.18 | 2021-2023 | |
| Daiichi Sankyo INC. | $83.49 | 2021-2023 | Injectafer |
| Scynexis, INC. | $74.36 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $73.94 | 2019-2023 | |
| Mylan Pharmaceuticals INC. | $51.84 | 2019-2022 | |
| Agile Therapeutics, INC. | $48.77 | 2021-2022 | |
| Shield Therapeutics INC | $42.34 | 2023 | Accrufer |
| Lupin INC. | $38.25 | 2019-2021 | |
| Therapeuticsmd, INC. | $31.61 | 2019-2021 | |
| Coopersurgical, INC. | $30.03 | 2021-2022 | |
| Hologic Sales and Service, LLC | $24.50 | 2022 | |
| Aspira Women'S Health INC | $21.91 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $16.44 | 2021 | |
| Duchesnay USA Incorporated | $15.89 | 2019 | |
| Medtronic, INC. | $14.23 | 2023 | Truclear |
| Biohaven Pharmaceuticals, INC. | $13.08 | 2020 | |
| Virtus Pharmaceuticals LLC | $12.69 | 2021 | |
| Amgen INC. | $12.26 | 2019 | |
| Avion Pharmaceuticals | $12.15 | 2022 | |
| Amag Pharmaceuticals, INC. | $12.04 | 2019 | |
| Evofem Biosciences, INC. | $11.60 | 2021 | |
| Allergan, INC. | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw T King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.